Indeed, Sestrin2 and 3 have a protective effect against obesity-induced metabolic dysfunction and insulin resistance, which is revealed by investigating the liver and adipose tissues of Sesn2/3 double knockout (DKO) mice (Lee et al., 2012). The gene discussed is SESN2; the disease is obesity disorder.